2021 annual financial data
Voyager Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -143.06%.
Operating income was -73,618,000 USD and net income was -66,032,000 USD.
Operating cash flow was -53,525,000 USD.
Get free Voyager Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 37,415,000 USD
- Operating income
- -73,618,000 USD
- Net income
- -66,032,000 USD
- Operating cash flow
- -53,525,000 USD